Comments
Loading...

Immuneering

IMRXNASDAQ
Logo brought to you by Benzinga Data
$2.18
0.041.87%
At close: -
$2.21
0.031.38%
After Hours: Dec 6, 6:02 PM EDT

Immuneering (NASDAQ:IMRX) Stock, Earnings Estimates, EPS, And Revenue

Immuneering reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Feb 28
EPS Estimate
$-0.430
Quarterly Revenue Estimate
Annual Revenue
(as of Sep 30)

Analyze the earnings history of Immuneering using advanced sorting and filters.

Data brought to you by Benzinga APIs

Immuneering (IMRX) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal Quarter EndDate ReportedActual EPSEstimated EPSSurprise %
Sep 20242024-11-13$-0.49$-0.5510.9 %
Jun 20242024-08-06$-0.47$-0.529.62 %
Mar 20242024-05-07$-0.49$-0.46-6.52 %
Dec 20232024-03-01$-0.52$-0.47-10.6 %

Immuneering (IMRX) Revenue

Quarterly Revenue Surprise Amount

Fiscal Quarter EndDate ReportedActual RevenueEstimated RevenueSurprise %
Mar 20232023-05-04$0$10.00K-100.0 %
Dec 20222023-03-06$456.00$60.00K-99.2 %
Sep 20222022-11-10$38.38K$150.00K-74.4 %
Jun 20222022-08-10$94.42K$180.00K-47.5 %

FAQ

Q

When is Immuneering (NASDAQ:IMRX) reporting earnings?

A

Immuneering (IMRX) is scheduled to report earnings on February 28, 2025. The last reported earnings were for reported on November 13, 2024 for Q3.

Q

What were the latest earnings per share (EPS) for Immuneering (NASDAQ:IMRX)?

A

The Actual EPS was $-0.49, which beat the estimate of $-0.55.

Q

What were Immuneering’s (NASDAQ:IMRX) revenues?

A

The Actual Revenue was $0K, which hit the estimate of $0K.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch